(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPL22L1 mRNA] CTD PMID:31150632 (1->4)-beta-D-glucan multiple interactions ISO RGD:1552260 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL22L1 mRNA CTD PMID:36331819 1,1-dichloroethene increases expression ISO RGD:1552260 6480464 vinylidene chloride results in increased expression of RPL22L1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1552260 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL22L1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1552260 6480464 Ethinyl Estradiol affects the expression of RPL22L1 mRNA CTD PMID:17555576 17beta-estradiol decreases expression ISO RGD:1602286 6480464 Estradiol results in decreased expression of RPL22L1 mRNA CTD PMID:23019147 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of RPL22L1 mRNA CTD PMID:32145629 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1552260 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1552260 6480464 Tetrachlorodibenzodioxin affects the expression of RPL22L1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of RPL22L1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1552260 6480464 Tetrachlorodibenzodioxin results in increased expression of RPL22L1 mRNA CTD PMID:15328365 2,3,7,8-Tetrachlorodibenzofuran increases expression EXP 6480464 2 more ... CTD PMID:32109520 2-hydroxypropanoic acid affects expression ISO RGD:1602286 6480464 Lactic Acid affects the expression of RPL22L1 mRNA CTD PMID:30851411 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1602286 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RPL22L1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RPL22L1 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1602286 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RPL22L1 mRNA CTD PMID:28628672 4-hydroxyphenyl retinamide decreases expression ISO RGD:1552260 6480464 Fenretinide results in decreased expression of RPL22L1 mRNA CTD PMID:28973697 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of RPL22L1 mRNA CTD PMID:28959563 aflatoxin B1 decreases expression ISO RGD:1602286 6480464 Aflatoxin B1 results in decreased expression of RPL22L1 mRNA CTD PMID:22100608 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of RPL22L1 mRNA CTD PMID:22484513 , PMID:23630614 aflatoxin B1 decreases expression ISO RGD:1552260 6480464 Aflatoxin B1 results in decreased expression of RPL22L1 mRNA CTD PMID:19770486 antirheumatic drug decreases expression ISO RGD:1602286 6480464 Antirheumatic Agents results in decreased expression of RPL22L1 mRNA CTD PMID:24449571 Aroclor 1254 increases expression ISO RGD:1552260 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of RPL22L1 mRNA CTD PMID:23650126 arsenite(3-) multiple interactions ISO RGD:1602286 6480464 arsenite promotes the reaction [G3BP1 protein binds to RPL22L1 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO RGD:1602286 6480464 Benzo(a)pyrene results in decreased expression of RPL22L1 mRNA CTD PMID:20106945 , PMID:21632981 benzo[a]pyrene increases expression ISO RGD:1552260 6480464 Benzo(a)pyrene results in increased expression of RPL22L1 mRNA CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1552260 6480464 Benzo(a)pyrene results in decreased expression of RPL22L1 mRNA CTD PMID:19770486 more ... benzo[a]pyrene multiple interactions ISO RGD:1552260 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of RPL22L1 mRNA] CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1602286 6480464 7 more ... CTD PMID:26238291 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1552260 6480464 Diethylhexyl Phthalate results in decreased expression of RPL22L1 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1552260 6480464 PPARA protein inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of RPL22L1 mRNA] CTD PMID:19850644 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of RPL22L1 mRNA CTD PMID:26496021 bisphenol A increases expression ISO RGD:1552260 6480464 bisphenol A results in increased expression of RPL22L1 mRNA CTD PMID:32156529 , PMID:33221593 bisphenol A affects expression ISO RGD:1602286 6480464 bisphenol A affects the expression of RPL22L1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO RGD:1602286 6480464 bisphenol A results in decreased expression of RPL22L1 mRNA CTD PMID:29275510 , PMID:29718440 bisphenol A multiple interactions ISO RGD:1602286 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RPL22L1 mRNA CTD PMID:28628672 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of RPL22L1 mRNA CTD PMID:25181051 , PMID:32145629 cadmium atom multiple interactions ISO RGD:1602286 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL22L1 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO RGD:1602286 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPL22L1 mRNA CTD PMID:35301059 casticin decreases expression ISO RGD:1552260 6480464 casticin results in decreased expression of RPL22L1 mRNA CTD PMID:28444820 chromium(6+) affects expression ISO RGD:1552260 6480464 chromium hexavalent ion affects the expression of RPL22L1 mRNA CTD PMID:28472532 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of RPL22L1 mRNA CTD PMID:17602206 copper atom decreases expression EXP 6480464 Copper results in decreased expression of RPL22L1 mRNA CTD PMID:30556269 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of RPL22L1 mRNA CTD PMID:30556269 crocidolite asbestos increases expression ISO RGD:1552260 6480464 Asbestos, Crocidolite results in increased expression of RPL22L1 mRNA CTD PMID:29279043 cyclosporin A increases expression ISO RGD:1602286 6480464 Cyclosporine results in increased expression of RPL22L1 mRNA CTD PMID:25562108 deoxynivalenol decreases expression ISO RGD:1602286 6480464 deoxynivalenol results in decreased expression of RPL22L1 mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO RGD:1602286 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RPL22L1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RPL22L1 mRNA CTD PMID:28628672 dicrotophos decreases expression ISO RGD:1602286 6480464 dicrotophos results in decreased expression of RPL22L1 mRNA CTD PMID:28302478 disodium selenite increases expression ISO RGD:1602286 6480464 Sodium Selenite results in increased expression of RPL22L1 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:1602286 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 entinostat increases expression ISO RGD:1602286 6480464 entinostat results in increased expression of RPL22L1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO RGD:1602286 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL22L1 mRNA CTD PMID:27188386 epoxiconazole increases expression ISO RGD:1552260 6480464 epoxiconazole results in increased expression of RPL22L1 mRNA CTD PMID:35436446 ethanol increases expression ISO RGD:1552260 6480464 Ethanol results in increased expression of RPL22L1 mRNA CTD PMID:30319688 flutamide increases expression EXP 6480464 Flutamide results in increased expression of RPL22L1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1552260 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of RPL22L1 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1602286 6480464 Formaldehyde results in decreased expression of RPL22L1 mRNA CTD PMID:23649840 genistein decreases expression ISO RGD:1552260 6480464 Genistein results in decreased expression of RPL22L1 mRNA CTD PMID:32186404 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of RPL22L1 mRNA CTD PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of RPL22L1 mRNA CTD PMID:24136188 hydrogen peroxide affects expression ISO RGD:1602286 6480464 Hydrogen Peroxide affects the expression of RPL22L1 mRNA CTD PMID:20044591 hydroxyurea decreases expression ISO RGD:1552260 6480464 Hydroxyurea results in decreased expression of RPL22L1 mRNA CTD PMID:12929121 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of RPL22L1 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1602286 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of RPL22L1 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of RPL22L1 mRNA CTD PMID:28628672 ivermectin decreases expression ISO RGD:1602286 6480464 Ivermectin results in decreased expression of RPL22L1 protein CTD PMID:32959892 lead diacetate decreases expression EXP 6480464 lead acetate results in decreased expression of RPL22L1 mRNA CTD PMID:22641619 methyl methanesulfonate decreases expression ISO RGD:1602286 6480464 Methyl Methanesulfonate results in decreased expression of RPL22L1 mRNA CTD PMID:23649840 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of RPL22L1 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of RPL22L1 mRNA CTD PMID:24136188 nitrofen increases expression EXP 6480464 nitrofen results in increased expression of RPL22L1 mRNA CTD PMID:33484710 ozone multiple interactions ISO RGD:1552260 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RPL22L1 mRNA CTD PMID:34911549 p-anisidine decreases expression ISO RGD:1552260 6480464 4-anisidine results in decreased expression of RPL22L1 mRNA CTD PMID:12929121 paclitaxel decreases expression ISO RGD:1552260 6480464 Paclitaxel results in decreased expression of RPL22L1 mRNA CTD PMID:12929121 paracetamol decreases expression ISO RGD:1602286 6480464 Acetaminophen results in decreased expression of RPL22L1 mRNA CTD PMID:22230336 paracetamol affects expression ISO RGD:1552260 6480464 Acetaminophen affects the expression of RPL22L1 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1602286 6480464 Acetaminophen results in increased expression of RPL22L1 mRNA CTD PMID:21420995 perfluorononanoic acid increases expression ISO RGD:1602286 6480464 perfluoro-n-nonanoic acid results in increased expression of RPL22L1 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1552260 6480464 perfluorooctane sulfonic acid results in decreased expression of RPL22L1 protein CTD PMID:26178269 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1552260 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of RPL22L1 mRNA CTD PMID:36331819 progesterone increases expression ISO RGD:1602286 6480464 Progesterone results in increased expression of RPL22L1 mRNA CTD PMID:21540246 propiconazole increases expression ISO RGD:1552260 6480464 propiconazole results in increased expression of RPL22L1 mRNA CTD PMID:21278054 rac-lactic acid affects expression ISO RGD:1602286 6480464 Lactic Acid affects the expression of RPL22L1 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1602286 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1602286 6480464 Silicon Dioxide analog results in increased expression of RPL22L1 mRNA CTD PMID:25895662 sodium arsenite decreases expression ISO RGD:1602286 6480464 sodium arsenite results in decreased expression of RPL22L1 mRNA, sodium arsenite results in decreased expression of RPL22L1 protein CTD PMID:30528433 , PMID:34032870 sodium dodecyl sulfate decreases expression ISO RGD:1602286 6480464 Sodium Dodecyl Sulfate results in decreased expression of RPL22L1 mRNA CTD PMID:31734321 tamoxifen affects expression ISO RGD:1552260 6480464 Tamoxifen affects the expression of RPL22L1 mRNA CTD PMID:17555576 testosterone multiple interactions EXP 6480464 [bisphenol A co-treated with Testosterone] results in increased expression of RPL22L1 mRNA CTD PMID:26496021 tetrachloroethene increases expression ISO RGD:1552260 6480464 Tetrachloroethylene results in increased expression of RPL22L1 mRNA CTD PMID:28973375 tetrachloromethane affects expression ISO RGD:1552260 6480464 Carbon Tetrachloride affects the expression of RPL22L1 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPL22L1 mRNA] CTD PMID:31150632 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of RPL22L1 mRNA CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of RPL22L1 mRNA CTD PMID:34492290 tolcapone decreases expression EXP 6480464 tolcapone results in decreased expression of RPL22L1 mRNA CTD PMID:24136188 trichostatin A increases expression ISO RGD:1602286 6480464 trichostatin A results in increased expression of RPL22L1 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1602286 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL22L1 mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate increases expression ISO RGD:1602286 6480464 tris(2-butoxyethyl) phosphate results in increased expression of RPL22L1 mRNA CTD PMID:29024780 tungsten increases expression ISO RGD:1552260 6480464 Tungsten results in increased expression of RPL22L1 mRNA CTD PMID:30912803 valproic acid affects expression ISO RGD:1602286 6480464 Valproic Acid affects the expression of RPL22L1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO RGD:1602286 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of RPL22L1 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:1602286 6480464 Valproic Acid results in decreased expression of RPL22L1 mRNA CTD PMID:27188386 , PMID:29154799 valproic acid increases expression ISO RGD:1602286 6480464 Valproic Acid results in increased expression of RPL22L1 mRNA CTD PMID:23179753 , PMID:26272509 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of RPL22L1 mRNA CTD PMID:22615374 , PMID:23034163